Smoking Cessation Aids Market Share

Statistics for the 2023 & 2024 Smoking Cessation Aids market share, created by Mordor Intelligence™ Industry Reports. Smoking Cessation Aids share report includes a market forecast to 029) and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Smoking Cessation Aids Industry

The smoking cessation aids market is fragmented due to the presence of small and large key players. Market players adopt several strategies, such as product launches, acquisitions, and mergers, to retain their market position. Also, the growing government initiatives to promote smoking cessation drugs and devices are further anticipated to propel market growth over the forecast period. Some of the key companies in the market are Pfizer Inc., NJOY, Johnson and Johnson, Takeda Pharmaceuticals Co. Ltd, Cipla Ltd, and GSK PLC.

Smoking Cessation Aids Market Leaders

  1. Johnson and Johnson

  2. Takeda Pharmaceuticals Co. Ltd.

  3. NJOY

  4. Pfizer Inc.

  5. Cipla Ltd.

*Disclaimer: Major Players sorted in no particular order

Smoking Cessation Aids Market Concentration

Smoking Cessation Aids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)